Supplier Marketing Spend Activity, Marketing and Sales Behaviors and Strategies in the Pharmaceutical Industry - 2012-2013 : Survey Intelligence
Publisher Name » ICD Research
Published Date » 2012-06-20
No. Of Pages » 75
- Analysis of opinions drawn from leading pharmaceutical industry executives.
- Analysis on how marketing expenditure, business strategies and practices in the pharmaceutical industry are set to change in 2012-2013.
- Analysis on spending plans, budget allocations, challenges and investment opportunities of supply decision makers.
This report is the result of an extensive survey drawn from ICD Researchs exclusive panel of leading pharmaceutical industry executives. It analyzes how marketing expenditure, business strategies and practices are set to change in the pharmaceutical industry in 2012-13. The report provides data on the current size of the marketing and advertising budgets of pharmaceutical industry supplier companies and how spending by industry suppliers will change, providing insight into global marketing behavior. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities.
Scope
- The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
- The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
- The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
- Key topics covered include marketing spend activity, marketing and sales behaviors and strategies.
- The report examines current practices and provides future expectations for the industry over the next 12-24 months.
- This report will help you to drive revenues by understanding future product investment areas and growth regions.
- This report will help you to formulate effective sales and marketing strategies by identifying how buyer budgets are changing and the direction of spend in the future.
- This report will help you to better promote your business by aligning your capabilities and business practices with your customers changing needs.
- This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
- This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
Table of Content
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Pharmaceutical Industry Supplier Marketing Spend Activity
3.1 Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers
3.1.1 Annual marketing budgets by region: global pharmaceutical industry suppliers
3.1.2 Annual marketing budgets by company turnover: global pharmaceutical industry suppliers
3.2 Planned Change in Marketing Expenditure Levels: Global Pharmaceutical Industry Suppliers
3.2.1 Planned change in marketing expenditure by region: global pharmaceutical industry suppliers
3.2.2 Planned change in marketing expenditure by turnover: global pharmaceutical industry suppliers
3.2.3 Planned change in marketing expenditure levels vs. revenue growth expectations (%), 2012
3.3 Future Investment by Media Channel: Global Pharmaceutical Industry Suppliers
3.3.1 Future investment by media channel by region: global pharmaceutical industry suppliers
3.3.2 Future investment by media channel by company turnover: global pharmaceutical industry suppliers
3.4 Global Pharmaceutical Industry Suppliers Future Investment in Marketing and Sales
3.4.1 Investment in marketing and sales by region: global pharmaceutical industry suppliers
3.4.2 Investment in marketing and sales by region: global pharmaceutical industry suppliers
3.4.3 Investment in marketing and sales by turnover: global pharmaceutical industry suppliers
4 Marketing and Sales Behaviors and Strategies in 2012-2013
4.1 Key Marketing Aims for 2012-2013: Global Pharmaceutical Industry Suppliers
4.1.1 Key marketing aims by region: global pharmaceutical industry suppliers
4.1.2 Key marketing aims by company turnover: global pharmaceutical industry suppliers
4.1.3 Key marketing aims by revenue growth expectations: global pharmaceutical industry suppliers
4.2 Essential Amendments to Marketing Activities in 2012-2013
4.2.1 Amendments to marketing activities by region: global pharmaceutical industry suppliers
4.2.2 Amendments to marketing activities by company turnover: global pharmaceutical industry suppliers
4.3 Use of New Media for Business Prospects: Global Pharmaceutical Industry Suppliers
4.3.1 Use of new media by region: global pharmaceutical industry suppliers
4.3.2 Use of new media by company turnover: global pharmaceutical industry suppliers
4.4 Critical Success Factors for Choosing a Marketing Agency
4.4.1 Critical success factors for choosing a marketing agency by region
4.4.2 Critical success factors for choosing a marketing agency by company turnover: global pharmaceutical industry suppliers
5 Appendix
5.1 Global Pharmaceutical Industry Survey Results - Closed Questions
5.2 Methodology
5.3 Contact us
5.4 About ICD Research
5.5 Disclaimer
List of Tables
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012
Table 8: Annual Marketing Budgets: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 9: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 10: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 11: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Table 12: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Table 13: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Table 14: Change in Marketing Expenditure Levels by Revenue Growth Expectations (%), 2012
Table 15: Net Change in Planned Marketing Expenditure, All Industries Comparison (%) 2012
Table 16: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Table 17: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 18: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 19: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 20: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Table 21: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 22: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 23: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Table 24: Use of New Media by Suppliers: Global Pharmaceutical Industry (%),2012
Table 25: Use of New Media by Region: Global Pharmaceutical Industry (%),2012
Table 26: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%),2012
Table 27: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2010-2012
Table 28: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Table 29: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Table 30: Survey Results - Closed Questions
List of Figures
Figure 2: Annual Marketing Budgets by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 3: Annual Marketing Budgets by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 4: Planned Change in Marketing Expenditure: Global Pharmaceutical Suppliers (%), 2010-2012
Figure 5: Planned Change in Marketing Expenditure Levels by Region (%), 2012
Figure 6: Planned Change in Marketing Expenditure Levels by Company Turnover (%), 2012
Figure 7: Future Investment by Media Channels : Global Pharmaceutical Industry Suppliers (%), 2012
Figure 8: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Region (%), 2012
Figure 9: Global Pharmaceutical Industry Suppliers: Investment in Media Channels by Turnover (%), 2012
Figure 10: Investment in Marketing and Sales: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 11: Investment in Marketing and Sales by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 12: Investment in Marketing and Sales by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 13: Key Marketing Aims: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 14: Key Marketing Aims by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 15: Key Marketing Aims by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 16: Key Marketing Aims by Revenue Growth Expectations: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 17: Amendments to Marketing Activities: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 18: Amendments to Marketing by Region: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 19: Amendments to Marketing by Turnover: Global Pharmaceutical Industry Suppliers (%) , 2012
Figure 20: Use of New Media by Suppliers: Global Pharmaceutical Industry (%), 2012
Figure 21: Use of New Media by Region: Global Pharmaceutical Industry (%), 2012
Figure 22: Use of New Media by Company Turnover: Global Pharmaceutical Industry (%), 2012
Figure 23: Critical Success Factors: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 24: Critical Success Factors by Region: Global Pharmaceutical Industry Suppliers (%), 2012
Figure 25: Critical Success Factors by Turnover: Global Pharmaceutical Industry Suppliers (%), 2012
Upcoming Reports:
|
Defoamers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
The global defoamers market is mainly driven by the growing demand from industries like petroleum, paint and coating and many more. Some other factors which are driving the global defoamers market include: government regulations regarding the use of VOC and eco friendly products dioxin free defoamers market is expected to grow. A chemical additive which helps in reducing the foam formation in liquids used for industrial application is known as defoamer. A defoamer is also called as an anti-foaming agent. It has a wide application in the industries. A defoamer is used to address both...
|
|
Global And China Petrochemical Market Analysis And Forecast (2010-2017)
By - Transparency Market Research
Petrochemical is one of the fastest growing segments in the chemical industry, registering double digit growth rate over the coming five years. There is a huge surge in the demand for petrochemicals across the globe. The demand for petrochemicals has grown multifold in China in the past decade. The chemicals which are covered in this report are Ethylene, Propylene, Benzene, Xylene and others. The report categorizes the petrochemical market into intermediates like PAN, MEG and LAB and polymers like PVC, Polyester, PET, and HDPE etc.
The research report analyses the economic trends,...
|
|
Membrane Bioreactor (MBR) Market Analysis, Market Size, Share, Trends, Growth And Forecast, 2012 - 2017
By - Transparency Market Research
Membrane bioreactor is a combination of various components which are used for waste water treatment. Membrane bioreactor incorporates two processes to treat water. The first step is a bioreactor, in which bacteria consumes organic material with the help of dissolved oxygen in the water, and the second step is a membrane module in which relatively pure water separates itself from organic matter and bacteria. These two units run step by step - firstly liquid flows through the bioreactor and then through the membrane separation process. Membrane bioreactors serve the municipal...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- The Future of the Haircare Market in Czech Republic to 2017
- The Future of the Haircare Market in Canada to 2017
- China Ophthalmic Hospital Industry Report, 2012 - 2015
- Global Food Industry Survey 2013-2014 - Market Trends, Buyer Spend and Procurement Strategies in the Global Food Industry
- The Future of the Haircare Market in Bulgaria to 2017
- Electricity Meters (Smart Meters) Market For Residential, Commercial And Industrial Applications - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Bed Linen Markets in the World to 2017 - Market Size, Trends, and Forecasts
- Bed Linen Markets in Europe to 2017 - Market Size, Trends, and Forecasts
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
